Science Current Events | Science News | Brightsurf.com
 

Research uncovers signaling pathways related to brain-immune system links

May 16, 2006
Cell biology studies may lay groundwork for a novel HIV treatment

New research on signaling pathways in immune cells bolsters evidence of connections between the central nervous system and the immune system. The findings may also advance the scientific foundation for a potential HIV treatment that may block the virus that causes AIDS.

The cell culture study by a research team from The Children's Hospital of Philadelphia and the University of Pennsylvania appears in the Proceedings of the National Academy of Sciences, published online on May 4.

The team, led by Steven D. Douglas, M.D., chief of the Section of Immunology at The Children's Hospital of Philadelphia, analyzed neurokinin-1 receptors found on the surfaces of monocytes, immune cells that develop into macrophages. The neurokinin-1 receptors (NK-1R) are docking sites for substance P, a well-known neurotransmitter that plays important roles in both immune function and the nervous system.

In the current study, the Douglas team investigated two forms of NK-1R in a human monocyte/macrophage cell line. One was a full-length receptor, the other a shortened version with fewer amino acids. When the researchers added substance P to cell cultures with the receptors, both responded with an increase in calcium ions, but used distinct signaling pathways.

The truncated NK-IR did not respond directly to substance P, but worked through another signaling molecule, the chemokine RANTES, to increase the calcium flow. The RANTES molecule is important because it binds to another cell receptor, CCR5, which is crucial in allowing common strains of HIV (R5 strains) to infect immune cells.

Significantly, when the investigators added the drug aprepitant, which binds to NK-1R, to their cell cultures, it inhibited signaling from both the full-length and short form of the receptors.

Although the current study was not focused on HIV infection, it directly relates to broader interests of Dr. Douglas' laboratory. He currently leads a four-year program project grant from the National Institute of Mental Health, entitled, "Neurokinin-1R (Substance P Receptor) Antagonists for HIV Therapy." One project within that grant will conduct a phase 1 (safety) trial of aprepitant in adults with HIV infection. Currently used as an anti-nausea medication, aprepitant, which has the trade name Emend, might also block HIV infection.

Because macrophages are a reservoir for HIV, a strategy that denies the virus entry into those immune cells may be important in combating HIV infection. Dr. Douglas showed in 2001 that another NK-1R antagonist blocked HIV replication within macrophages in cell culture. The hope is that aprepitant may show a similar protective effect in patients.

"We postulate that blocking NK-1R may send signals to turn off the CCR5 receptor for HIV, closing the door to the virus," said Dr. Douglas. "Underlying the signaling mechanisms are the questions, 'how does the immune system talk to the nervous system?' and 'how does the nervous system talk back?' Substance P is a link between both systems, and this study increases our understanding of those underlying questions."

Children's Hospital of Philadelphia


Related Immune Cells Current Events and Immune Cells News Articles


More genetic clues found in a severe food allergy
Scientists have identified four new genes associated with the severe food allergy eosinophilic esophagitis (EoE). Because the genes appear to have roles in other allergic diseases and in inflammation, the findings may point toward potential new treatments for EoE.

Bacterial infections suppress protective immune response in neurodermatitis
The skin condition neurodermatitis affects nearly one in four children and also occurs frequently in adults.

MSK team makes key discovery in understanding immunotherapy's successes -- and its failures
A collaborative team of leaders in the field of cancer immunology from Memorial Sloan Kettering Cancer Center has made a key discovery that advances the understanding of why some patients respond to ipilimumab, an immunotherapy drug, while others do not.

Fat a culprit in fibrotic lung damage
Pulmonary fibrosis has no cure. It's caused by scarring that seems to feed on itself, with the tougher, less elastic tissue replacing the ever moving and stretching lung, making it increasingly difficult for patients to breathe.

Mind the gap -- how new insight into cells could lead to better drugs
Professor Dan Davis and his team at the Manchester Collaborative Centre for Inflammation Research, working in collaboration with global healthcare company GSK, investigated how different types of immune cells communicate with each other - and how they kill cancerous or infected cells.

Side effects of possible anti-cancer strategy discovered
The Malt1 protein is one of the most important control centers in human immune cells and a real all-rounder.

Infection-fighting B cells go with the flow
Newly formed B cells take the easy way out when it comes to exiting the bone marrow, according to a study published in The Journal of Experimental Medicine.

Novel cancer vaccine approach for brain tumors
Glioblastoma is the most common aggressive primary brain tumor, and despite advances in standard treatment, the median survival is about 15 months (compared to 4 months without treatment).

HIV virulence depends on where virus inserts itself in host DNA
The human immunodeficiency virus (HIV) can insert itself at different locations in the DNA of its human host - and this specific integration site determines how quickly the disease progresses, report researchers at KU Leuven's Laboratory for Molecular Virology and Gene Therapy.

Collaborative Penn-Dresden Study Blocks Multiple Sclerosis Relapses in Mice
In multiple sclerosis, the immune system goes rogue, improperly attacking the body's own central nervous system. Mobility problems and cognitive impairments may arise as the nerve cells become damaged.
More Immune Cells Current Events and Immune Cells News Articles

The Immune System Recovery Plan: A Doctor's 4-Step Program to Treat Autoimmune Disease

The Immune System Recovery Plan: A Doctor's 4-Step Program to Treat Autoimmune Disease
by Susan Blum (Author), Mark Hyman (Foreword), Michele Bender (Foreword)


• Are you constantly exhausted?

• Do you frequently feel sick?

• Are you hot when others are cold, or cold when everyone else is warm?

• Do you have trouble thinking clearly, aka “brain fog”?

• Do you often feel irritable?

• Are you experiencing hair loss, dry skin, or unexplained weight fluctuation?

• Do your joints ache or swell but you don’t know why?

• Do you have an overall sense of not feeling your best, but it has been going on so long it’s actually normal to you?

IF you answered yes to any of these questions, you may have an autoimmune disease, and this book is the “medicine” you need. Among the most prevalent forms of chronic illness in this country, autoimmune disease affects...

The Functional and Translational Immunology of Regulatory T Cells (Tregs), the Anti-Tumor T Cell Response, and Cancer (Immunology and Immune System Disorders)

The Functional and Translational Immunology of Regulatory T Cells (Tregs), the Anti-Tumor T Cell Response, and Cancer (Immunology and Immune System Disorders)
by Michael A. Alexander (Author)


Cancer can grow without the ability of the T cell immune system to stop it.  This book examines the role regulatory T cells (Tregs) play in inhibiting the anti-tumor T cell response.  Though Tregs protect the tissues from attach by the T cell immune system and thereby prevent autoimmunity, these T cells are a major reason why anti-cancer therapies do not work.  Tregs view tumor cells as cells that are damaged and need time to get back to normal.  This never happens with cancer and that's why it kills us.  There is a detailed description of this most advanced effector T cell and how it and it alone can result in the deaths of millions by cancer.

Primer to the Immune Response: Academic Cell Update Edition

Primer to the Immune Response: Academic Cell Update Edition
by Tak W. Mak (Author), Mary E. Saunders (Author)


Primer to the Immune Response effectively presents complex immunological concepts. The book is divided into two parts, which cover basic immunology and clinical immunology.
Part I presents the history and nature of immune response, and it describes the general features of the innate and adaptive immune responses. This part also explores the components of the immune system such as the cells and tissues. It also illustrates the intracellular communication through signal induction, intercellular communication through cytokines, and the cellular movement in the immune system. Furthermore, this part discusses proteins and genes, the development, activation and effector functions of both B cells and T cells.
Part II focuses on clinical immunology and covers immunity to infection caused...

The Immune System, 3rd Edition

The Immune System, 3rd Edition
by Peter Parham (Author)


The Immune System, Third Edition emphasizes the human immune system and synthesizes immunological concepts into a comprehensible, up-to-date, and reader-friendly account of how the immune system works.  Written for undergraduate, medical, veterinary, dental, and pharmacy students in immunology courses, it makes generous use of medical examples to illustrate points.  The Third Edition has been extensively revised and updated and includes two new chapters on innate and adaptive immunity, which explore the physical, cellular, and molecular principles underlying these responses to infection.  It also features enhanced coverage of aspects of innate immunity such as the complement system, Toll-like receptors, defensins, and C-reactive protein; the role of dendritic cells in initiating...

Cell Wars (Cells and Things)

Cell Wars (Cells and Things)
by Fran Balkwill (Author), Frances R. Balkwill (Author), MIC Rolph (Illustrator)


Explains how cells fight off diseases and viruses in the human body.

B Cells: Molecular Biology, Developmental Origin and Impact on the Immune System (Cell Biology Research Progress)

B Cells: Molecular Biology, Developmental Origin and Impact on the Immune System (Cell Biology Research Progress)
by Robert L. Montes (Author), Robert L. Montes (Editor), Leo Reyes (Editor)


B cells belong to a group of white blood cells known as lymphocytes, making them a vital part of the immune system. The human body makes millions of different types of B cells each day that circulate in the blood and lymphatic system performing the role of immune surveillance. They do not produce antibodies until they become fully activated. In this book, the authors present current research in the study of the molecular biology, developmental origin and impact on the immune system of B cells. Topics discussed include the role of B cells in intracellular bacterial pathogen infections; dynamic clustering of BCR-lipid rafts in antigen affinity discrimination by B cells; and B cells as a key player in the pathogenesis of multiple sclerosis.

The Immune System Cure: Optimize Your Immune System in 30 Days-The Natural Way!

The Immune System Cure: Optimize Your Immune System in 30 Days-The Natural Way!
by Lorna Vanderheaghe (Author)


What causes one person to catch a cold or flu and another to avoid it? Why do serious outbreaks of infectious diseases leave some individuals untouched? What allows someone to be incapacitated by allergies? The answer lies within nature itself-our immune system. The Immune System Cure provides simple techniques for supercharging your immune system to resist and prevent disease. Through diet, exercise, stress reduction and nutritional supplements, including plant sterols and sterolins, you can harness the power of your immune system in just 30 days and help it combat: Antibiotic-resistant bacteria Fibromyalgia Allergies Hepatitis C Tuberculosis Cancer Rheumatoid arthritis and other autoimmune diseases Chronic fatigue syndrome and more Now you can maintain a healthy natural resistance to...

Guide to Signal Pathways in Immune Cells

Guide to Signal Pathways in Immune Cells
by E. Nigel Wardle (Author)


To read current biomedical science, one has to have a working knowledge of how important effector molecules cause transduction of their signal within cells, altering the control of genes. This work aims to provide that basic knowledge for medical readers. Students of immunology or cell biology will note its relevance. One will learn how platelets, macrophages, neutrophils, T and B lymphocytes and natural killer cells perform their functions and how skin, breast, prostate and colon cancers emerge. The associated diagrams and tables are used to obviate extensive text. Appropriate references to articles and reviews by workers in each field are given so that further consideration can easily be undertaken. We are all at differing stages of our appreciation of immunology and of pat- physiology....

Antibodies that Cause Thyroid Diseases and Symptoms: Immune Cells causing Hypothyroidism & Hyperthyroidism

Antibodies that Cause Thyroid Diseases and Symptoms: Immune Cells causing Hypothyroidism & Hyperthyroidism
by James M. Lowrance (Author)


The majority of patients with both hypothyroidism (under-active thyroid) and hyperthyroidism (overactive thyroid) are experiencing autoimmune diseases that cause these conditions. When autoimmune thyroid disease results in hypothyroidism, the term for the disease is "Hashimoto's thyroiditis." When the autoimmune disease of the thyroid causes hyperthyroidism, it is called "Grave's Disease." Thyroid antibodies attack key proteins in the thyroid gland and in some cases, stimulate production of excessive amounts of hormone. These killer cells that are manufactured by the immune system become confused for reasons yet to be fully understood by medical science and they begin to identify thyroid cells as threats in the body. As they attack these cells, the thyroid gland becomes damaged, resulting...

Cancer Immunotherapy, Second Edition: Immune Suppression and Tumor Growth

Cancer Immunotherapy, Second Edition: Immune Suppression and Tumor Growth
by George C. Prendergast (Editor), Elizabeth M. Jaffee (Editor)


There has been major growth in understanding immune suppression mechanisms and its relationship to cancer progression and therapy. This book highlights emerging new principles of immune suppression that drive cancer, and it offers radically new ideas about how therapy can be improved by attacking these principles. Following work that firmly establishes immune escape as an essential trait of cancer, recent studies have now defined specific mechanisms of tumor immune suppression. It also demonstrates how attacking tumors with molecular targeted therapeutics or traditional chemotherapeutic drugs can produce potent anti-tumor effects in preclinical models. This book provides basic, translational, and clinical cancer researchers with an indispensable overview of immune escape as a critical...

© 2014 BrightSurf.com